By Josh White
Date: Friday 20 Sep 2024
(Sharecast News) - GENinCode announced a collaboration with the Family Heart Foundation, UT Southwestern, and other partners on Friday, to implement its LIPID inCode genetic test for diagnosing familial hypercholesterolemia (FH) in primary and secondary care settings across the United States.
By Josh White
Date: Wednesday 19 Jul 2023
(Sharecast News) - Predictive generics specialist GENinCode announced a collaboration with MedStar Health on Wednesday - a prominent 10-hospital health system in the Washington, DC area of the United States.
By Josh White
Date: Tuesday 03 Jan 2023
(Sharecast News) - Predictive genetics specialist GENinCode announced California state licensing approval and CLIA certification of its Irvine laboratory on Tuesday, enabling it to provide its products for the risk assessment of cardiovascular disease (CVD) to patients across 49 states in the US.
Currency | UK Pounds |
Share Price | 3.52p |
Change Today | -0.030p |
% Change | -0.85 % |
52 Week High | 9.63 |
52 Week Low | 3.20 |
Volume | 69,761 |
Shares Issued | 176.96m |
Market Cap | £6.23m |
Beta | 0.06 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
08:57 | 27,688 @ 3.60p |
08:30 | 845 @ 3.52p |
08:08 | 2,500 @ 3.50p |
08:08 | 27 @ 3.60p |
08:08 | 11,027 @ 3.60p |
CEO | Matthew Heaton Walls |
CFO | Paul Andrew Peter Foulger |
COO | Jordi Puig Gilberte |
You are here: research